According to filings with the U.S. Securities and Exchange Commission, Korio is raising $6,786,108.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Ryan Keane played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Korio
Korios mission is to enable people to achieve more with clinical technology. By infusing into our platform the industrys top subject matter experts unique and powerful ways of navigating todays complex protocol designs, the Korio platform transforms the status quo by enabling trial set up and management to be performed with confidence, in less time and with predictable, consistent outcomes. Reflecting decades of hands-on IRT experience across thousands of trial designs, Korio enables once aspirational goals around IRT feature reusability, process repeatability, system performance, and overall system quality by embedding the IRT workflow into the software itself.

To learn more about Korio, visit http://www.korioclinical.com/

Contact:
Ryan Keane, President and Chief Executive Officer
415-531-5917

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.